Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2019 Feb 14;25(3):245–263. doi: 10.3350/cmh.2018.0090

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2019 by The Korean Association for the Study of the Liver

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

PMC Copyright notice

Figure 5. — Diagnostic algorithm and recall policy in cirrhotic liver according to European Association for the Study of the Liver (EASL). Reprint with permission from EASL.12 US, ultrasonography; mo, months; CT, computed tomography; MRI, magnetic resonance imaging; HCC, hepatocellular carcinoma. *Using extracellular magnetic resonance contrast agents or gadobenate dimeglumine; ^†Using the following diagnostic criteria: arterial phase hyperenhancement (APHE) and washout on the portal venous phase; ^‡Using the following diagnostic criteria: APHE and mild washout after 60 seconds; ^§Lesion <1 cm stable for 12 months (three controls after four months) can be shifted back to regular 6 months surveillance; ||Optional for centre-based programmes.